Aprotinin administration and disseminated intravascular coagulation.
Ramsay
M A
MA
D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D007611:Aprotinin / Q000009:adverse effects / Q000627:therapeutic use*; D004211:Disseminated Intravascular Coagulation / Q000139:chemically induced / Q000188:drug therapy*; D005342:Fibrinolysis; D006490:Hemostatics / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D016031:Liver Transplantation; D012307:Risk Factors
D000933:Antifibrinolytic Agents; D006490:Hemostatics; D007611:Aprotinin